Sélection d’articles sur les phéochromocytomes et paragangliomes

Février 2017

Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo
      Lee M et al. – Endocr Relat Cancer. 2017 Jan;24(1):1-15. Epub 2016 Nov 3.
Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma
      Bahougne T et al – Endocr Relat Cancer. 2017 Feb;24(2):L7-L11. doi: 10.1530/ERC-16-0431. Epub 2016 Nov 28

The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma.
      Castro-Vega LJ et al – J Clin Endocrinol Metab. 2016 Dec;101(12):4764-4768. Epub 2016 Sep 28.

Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations
      Daniel E et al. – Eur J Endocrinol. 2016 Dec;175(6):561-570. Epub 2016 Sep 15
Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis
      Amar L et al. – Eur J Endocrinol. 2016 Oct;175(4):R135-45. doi: 10.1530/EJE-16-0189. Epub 2016 Apr 14.
Germline mutations and genotype–phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
      Pandit R et al. –  Eur J Endocrinol. 2016 Dec;175(7)311-323 X3
Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1
      Képénékian L et al. – Eur J Endocrinol. 2016 Oct;175(4):335-44. doi: 10.1530/EJE-16-0233. Epub 2016 Jul 22.

Janvier 2017

Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.
      NGS in PPGL (NGSnPPGL) Study Group. Toledo RA et al. – Nat Rev Endocrinol. 2016 Nov 18. doi: 10.1038/nrendo.2016.185.

 

A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL
     Bourdeau I et al – J Clin Endocrinol Metab. 2016 Dec;101(12):4710-4718. Epub 2016 Oct 4
The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma
      Castro-Vega LJ et al. – J Clin Endocrinol Metab. 2016 Dec;101(12):4764-4768. Epub 2016 Sep 28

Novel insights into the polycythemia–paraganglioma–somatostatinoma syndrome
      Därr R et al. – Endocr Relat Cancer. 2016 Dec;23(12):899-908. Epub 2016 Sep 27
Endocrine tumors associated with the vagus nerve
      Varoquaux A et al. – Endocr Relat Cancer. 2016 Sep;23(9):R371-9. doi: 10.1530/ERC-16-0241. Epub 2016 Jul 12

Juillet 2016

European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma
      Plouin PF et al. Eur J Endocrinol 2016 May;174(5):G1-G10. doi: 10.1530/EJE-16-0033

Mars 2016

Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas
      Richter S et al. – J Clin Endocrinol Metab. 2016 Feb;101(2):359-63. doi: 10.1210/jc.2015-3856. Epub 2015 Dec 11.
Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis.
      Korpershoek E et al. –  J Clin Endocrinol Metab. 2016 Feb;101(2):453-60. doi: 10.1210/jc.2015-2592. Epub 2015 Dec 15.
Cushing Syndrome Due to ACTH-Secreting Pheochromocytoma, Aggravated by Glucocorticoid-Driven Positive-Feedback Loop.
      Sakuma I et al. – J Clin Endocrinol Metab. 2016 Mar;101(3):841-6. doi: 10.1210/jc.2015-2855. Epub 2015 Dec 23.
Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.
      Flynn A et al.  – J Clin Endocrinol Metab. 2016 Mar;101(3):1034-43. doi: 10.1210/jc.2015-3889. Epub 2016 Jan 21.

Longitudinal plasma metanephrines preceding pheochromocytoma diagnosis: a retrospective case–control serum repository study
      S W Olson et al. – Eur J Endocrinol 174 (3) 289-295, doi: 10.1530/EJE-15-0651

Janvier 2016

 

Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome Aufforth R.D. et al.
      J Clin Endocrinol Metab. 2015 Dec;100 (12) :4498-504. doi: 10.1210/jc.2015-3045. Epub 2015 Oct 9.

 

Management Of Endocrine Disease: Outcome of adrenal sparing surgery in heritable pheochromocytoma Castinetti F. et al.
      Eur J Endocrinol. 2016 Jan;174 (1):R9-R18. doi: 10.1530/EJE-15-0549. Epub 2015 Aug 21. Review.